Detalles de la búsqueda
1.
Significance of detectable HCV RNA below the limit of quantification in patients treated with DAAs using standard and ultrasensitive protocols.
J Med Virol
; 90(7): 1264-1271, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29611880
2.
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study.
Clin Transplant
; 32(2)2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29193356
3.
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.
Liver Transpl
; 22(4): 446-58, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26890629
4.
Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter observational study.
BMC Infect Dis
; 16(1): 401, 2016 Aug 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-27515949
5.
Risk and predictive factors of prolonged viral RNA shedding in upper respiratory specimens in a large cohort of COVID-19 patients admitted to an Italian reference hospital.
Int J Infect Dis
; 105: 532-539, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33676001
6.
Clinical and virological properties of hepatitis C virus genotype 4 infection in patients treated with different direct-acting antiviral agents.
Infect Drug Resist
; 11: 2117-2127, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30464554
7.
Immunohistochemical study of apelin, the natural ligand of receptor APJ, in a case of AIDS-related cachexia.
In Vivo
; 16(5): 337-40, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12494874
8.
Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis.
J Int AIDS Soc
; 17(4 Suppl 3): 19802, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25397546
9.
Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort.
J Int AIDS Soc
; 17(4 Suppl 3): 19812, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25397556
10.
Switching to Coformulated Rilpivirine/Emtricitabine/Tenofovir in Virologically Suppressed Patients: Data From a Multicenter Cohort.
J Acquir Immune Defic Syndr
; 70(4): e147-50, 2015 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26090757
11.
Yersinia pseudotuberculosis septicemia and HIV.
Emerg Infect Dis
; 11(7): 1128-30, 2005 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16022797
Resultados
1 -
11
de 11
1
Próxima >
>>